Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Alcohol Drinking 11Pancreatic Neoplasms 7Neoplasms 5Smoking Cessation 4Pancreatic Cyst 4Cancer Pain 4Agnosia 4Smoking 3Pain 3Depression 3Prostatic Neoplasms 2Postoperative Complications 2Neoplasms, Cystic, Mucinous, and Serous 2Multiple Endocrine Neoplasia Type 1 2Lymphoma, Follicular 2Lymphoma 2Leukemia 2Infections 2Head and Neck Neoplasms 2Gliosarcoma 2Glioblastoma 2Condylomata Acuminata 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Cardiovascular Diseases 2Breast Neoplasms 2Brain Neoplasms 2Alcoholism 2Wounds and Injuries 1Warts 1

Interventions

pembrolizumab 157Gemcitabine 140Capecitabine 123Paclitaxel 121Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Docetaxel 98Leucovorin 97Cisplatin 90Radiosurgery 88Irinotecan 88Carboplatin 86Cyclophosphamide 72Cetuximab 72Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Ethanol × Clear all
NCT00009854 2013-11-06

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

National Cancer Institute (NCI)

Phase 1/2 Unknown
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡